OXFORD IMMUNOTEC GLOBAL PLC $40,000,000 ORDINARY SHARES SALES AGREEMENTSales Agreement • December 21st, 2016 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • New York
Oxford Immunotec Global PLC (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
